Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.11 | 31.49 |
| PEG Ratio (TTM) | -0.04 | 1.78 |
| P/S Ratio (TTM) | 0.64 | 2.24 |
| P/B Ratio (TTM) | 2.00 | 2.82 |
| P/FCF Ratio (TTM) | -0.58 | 15.75 |
| Price to 5YR AVG Earnings Ratio | N/A | 8.40 |
| Price to 5YR AVG FCF Ratio | N/A | 46.54 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -28.89% | 7.34% |
| ROE (TTM) | -146.70% | 13.06% |
| Net Profit Margin (TTM) | -57.99% | 8.11% |
| ROIC 5YR AVG | N/A | 11.95% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.88% | 194.87% | N/A |
| Revenue | 26.95% | -9.45% | N/A |
| Net Income | -17.60% | 882.89% | N/A |
| Cash Flow | -0.34% | 857.99% | N/A |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.93 | 2.43 |
| Quick Ratio (TTM) | 0.89 | 2.37 |
| D/E Ratio (TTM) | 1.32 | 0.29 |
| Interest Coverage (TTM) | -12.86 | 17.46 |
| Piotroski F-Score | N/A | 6 |
| Altman Z-Score | N/A | 4.75 |
| LTL to 5YR AVG FCF | N/A | 5.80 |
| Shares Outstanding Growth 5YR AVG | N/A | 100.69% |